Alto Neuroscience ANRO Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's shares (diluted)?
- Alto Neuroscience (ANRO) reported shares (diluted) of 32.9M in Q1 2026.
- How has Alto Neuroscience's shares (diluted) changed year-over-year?
- Alto Neuroscience's shares (diluted) increased by 21.6% year-over-year, from 27M to 32.9M.
- What is the long-term trend for Alto Neuroscience's shares (diluted)?
- Over 2 years (2023 to 2025), Alto Neuroscience's shares (diluted) has grown at a 172.0% compound annual growth rate (CAGR), from 14.9M to 110.1M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.